Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Emma Guttman‐Yassky, Kenji Kabashima, Delphine Staumont‐Salle, Walter K. Nahm, Sylvia Pauser, Joel Correa Da Rosa, Britta Cathrina Martel, Daniel Elenius Madsen, Mads Røpke, Petra Arlert, Louise Steffensen, Andrew Blauvelt, Kristian Reich
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet